FDA Inspection 988705 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 3008887707

The FDA completed an inspection of Fresenius Kabi USA, LLC on June 24, 2016 in Wilson, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 24, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wilson, NC (United States)

Citations

IDCFRDescription
163021 CFR 211.130(b)Unlabeled filled containers controls
180921 CFR 211.160(a)Following/documenting laboratory controls
202421 CFR 211.188(b)(12)Documentation of Batch Investigations